Annual report pursuant to Section 13 and 15(d)

ACCRUED EXPENSES

v3.10.0.1
ACCRUED EXPENSES
12 Months Ended
Dec. 31, 2018
Payables and Accruals [Abstract]  
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
7.
ACCRUED EXPENSES
 
Supply of CLR 131
 
Accounts payable and accrued liabilities approximately consist of the following:
 
 
 
2018
 
 
2017
 
 
 
 
 
 
 
 
Incentive compensation
 
$
408,000
 
 
$
341,000
 
Accounts payable
 
 
612,000
 
 
 
933,000
 
Clinical
study
costs
 
 
332,000
 
 
 
329,000
 
Professional fees
 
 
64,000
 
 
 
178,000
 
Insurance
 
 
69,000
 
 
 
 
Other
 
 
59,000
 
 
 
87,000
 
 
 
$
1,544,000
 
 
$
1,868,000